Glycoprotein IIb/IIIa inhibitor use in cardiogenic shock complicating myocardial infarction: The Portuguese Registry of Acute Coronary Syndromes

Glycoprotein IIb/IIIa inhibitor use in cardiogenic shock complicating myocardial infarction: The Portuguese Registry of Acute Coronary Syndromes

Introduction and objectives: Cardiogenic shock (CS) complicates 5–10% of cases of myocardial infarction (MI). Whether glycoprotein IIb/IIIa inhibitors (GPIs) are beneficial in these patients is controversial. Our aim is to assess the prognostic impact of GPI use on in-hospital mortality and outcomes...

Full description

Bibliographic Details
Main Authors: Carolina Saleiro, Diana de Campos, Joana M. Ribeiro, João Lopes, Luís Puga, José P. Sousa, Ana Rita M. Gomes, Alexandrina Siserman, Carolina Lourenço, Lino Gonçalves
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Revista Portuguesa de Cardiologia
Subjects:
Enfarte agudo do miocárdio
Choque cardiogénico
Inibidores da glicoproteína IIb/IIIa
Online Access:http://www.sciencedirect.com/science/article/pii/S087025512200364X

Internet

http://www.sciencedirect.com/science/article/pii/S087025512200364X

Similar Items